ABCL-170: Long-Term Outcomes from the Phase II L-MIND Study of Tafasitamab (MOR208) Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

2020 ◽  
Vol 20 ◽  
pp. S267-S268
Author(s):  
Gilles Salles ◽  
Johannes Duell ◽  
Eva González-Barca ◽  
Wojciech Jurczak ◽  
Anna Marina Liberati ◽  
...  
2018 ◽  
Vol 185 (1) ◽  
pp. 140-142 ◽  
Author(s):  
Anuhya Kommalapati ◽  
Sri Harsha Tella ◽  
Ronald S. Go ◽  
Grzegorz S. Nowakowski ◽  
Gaurav Goyal

2014 ◽  
Vol 55 (10) ◽  
pp. 2387-2388 ◽  
Author(s):  
Qi-Chun Cai ◽  
Yan Gao ◽  
Xiao-Xiao Wang ◽  
Qing-Qing Cai ◽  
Ze-Xiao Lin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document